|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 9.600 USD | -1.13% |
|
-.--% | - |
| 25-05-22 | OptiNose, Inc.(NasdaqGS:OPTN) dropped from S&P Global BMI Index | CI |
| 25-05-22 | OptiNose, Inc.(NasdaqGS:OPTN) dropped from S&P TMI Index | CI |
| Capitalization | 97.22M 82.82M 76.65M 72.17M 134M 9.04B 137M 899M 352M 4.34B 365M 357M 15.47B | P/E ratio 2023 |
-4.07x | P/E ratio 2024 | -3.15x |
|---|---|---|---|---|---|
| Enterprise value | 142M 121M 112M 105M 196M 13.18B 200M 1.31B 513M 6.33B 532M 520M 22.55B | EV / Sales 2023 |
2.86x | EV / Sales 2024 | 1.43x |
| Free-Float |
6.25% | Yield 2023 * |
-
| Yield 2024 | - |
| 1 day | -1.13% |
| 1 year | 9.05 |  | 9.75 |
| 3 years | 4.82 | | 31.5 |
| 5 years | 4.82 | | 64.5 |
| 10 years | 4.82 | | 450 |
| Manager | Title | Age | Since |
|---|---|---|---|
Evan Loh
CEO | Chief Executive Officer | 67 | 2025-05-20 |
| Chief Tech/Sci/R&D Officer | - | 2019-12-31 | |
Jonathan Neely
IRC | Investor Relations Contact | - | 2020-07-31 |
| Director | Title | Age | Since |
|---|---|---|---|
Evan Loh
BRD | Director/Board Member | 67 | 2025-05-20 |
| Name | Varia. Jan 1. | Weight | AuM | |
|---|---|---|---|---|
 | -5.90% | 0% | 293,477 M€ |
| Change | 5d. change | 1-year change | 3-years change | Capi.($) | ||
|---|---|---|---|---|---|---|
| -1.13% | -.--% | +6.08% | -65.41% | 97.22M | |
| -1.65% | +0.42% | +30.32% | +155.99% | 841B | |
| -1.18% | -1.88% | +60.37% | +45.12% | 574B | |
| -2.10% | -0.43% | +19.37% | +28.93% | 368B | |
| -0.09% | 0.00% | +30.86% | +15.85% | 320B | |
| -0.30% | -0.56% | +52.03% | +30.17% | 318B | |
| -1.03% | +0.46% | +56.57% | +7.82% | 300B | |
| -0.34% | -1.17% | +43.74% | +39.79% | 295B | |
| -1.29% | +0.89% | +24.74% | +39.90% | 189B | |
| -2.18% | -0.52% | +37.07% | +68.27% | 173B | |
| Average | -0.75% | +0.25% | +36.11% | +36.64% | 337.8B | |
| Weighted average by Cap. | -0.64% | +0.00% | +39.87% | +63.87% |
| 2023 | 2024 | |
|---|---|---|
| Net sales | 70.99M 60.47M 55.97M 52.7M 98.16M 6.6B 100M 657M 257M 3.17B 266M 261M 11.3B | 78.23M 66.64M 61.67M 58.07M 108M 7.28B 110M 724M 283M 3.49B 294M 287M 12.45B |
| Net income | -35.48M -30.23M -27.97M -26.34M -49.06M -3.3B -50.07M -328M -128M -1.58B -133M -130M -5.65B | -21.54M -18.35M -16.98M -15.99M -29.79M -2B -30.4M -199M -77.96M -962M -80.84M -79.12M -3.43B |
| Net Debt | 58.06M 49.47M 45.78M 43.1M 80.29M 5.4B 81.93M 537M 210M 2.59B 218M 213M 9.24B | 44.48M 37.89M 35.06M 33.02M 61.5M 4.14B 62.76M 411M 161M 1.99B 167M 163M 7.08B |
Employees
128
Sector
Pharmaceuticals
- Stock Market
- Equities
- OPTN Stock
Select your edition
All financial news and data tailored to specific country editions
